Table 1. A list of patients included in GnRH agonist and GnRH antagonist group with a number CC samples regarding to oocyte stage.
Patient | Therapy group | CC MI | CC MII-NF | CC MI-BL |
1 | GnRH agonist | 1 | 1 | |
2 | GnRH agonist | 1 | 1 | 1 |
3 | GnRH agonist | 1 | 1 | |
4 | GnRH agonist | 1 | 1 | |
5 | GnRH agonist | 1 | 1 | 1 |
6 | GnRH agonist | 1 | 1 | 1 |
7 | GnRH agonist | 1 | 1 | |
8 | GnRH agonist | 1 | 1 | |
9 | GnRH agonist | 1 | 1 | |
10 | GnRH agonist | 2 | 1 | |
11 | GnRH agonist | 1 | 1 | |
12 | GnRH antagonist | 1 | 1 | |
13 | GnRH antagonist | 1 | 1 | |
14 | GnRH antagonist | 1 | 1 | |
15 | GnRH antagonist | 1 | 1 | |
16 | GnRH antagonist | 1 | 1 | |
17 | GnRH antagonist | 1 | 1 | |
18 | GnRH antagonist | 1 | 1 | |
19 | GnRH antagonist | 1 | 1 | |
20 | GnRH antagonist | 1 | 1 | |
21 | GnRH antagonist | 1 | 1 |
CC MI: cumulus cells of metaphase I oocytes; CC MII-NF: cumulus cells of unfertilized metaphase II oocytes; CC MII-BL: cumulus cells of metaphase II oocytes developed to blastocyst stage embryo.